• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of June 5, 2013

  • Print
  • Share
  • E-mail
-

Event Detail

Event ID 44633
Product Type Biologics
Status Terminated
Recalling Firm American National Red Cross (The)
City Cleveland
State OH
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2007-02-01
Initial Firm Notification of
Consignee or Public
Telephone
Distribution Pattern Ohio

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Red Blood Cells Leukocytes Reduced 42FG97856; 42FX18928; 42FS77056; 42FW04560; 42FS77179; 42T14091; 42FW07587; 42FE77508; 42X69153; 42FT30987; 42FT32094; 42FT33242; 42Q80247; 42FX23314; 42FW14032; 42Y40592; 42K62728; 42FW15079; 42FP95695; 42T21726; 42FY46506; 42GC04041; 42FP95993; 42FW16055; 42FW16474; 42FJ17909; 42FY47360; 42E44031; 42GC04913; 42K65715; 42GC05249; 42K67824; 42GE10615; 42J50877; 42GE13124; 42K72330; 42FE88710; 42FX31697; 42FY54263; 42L17022; 42FE89129; 42FR09116; 42L17139; 42FY54595; 42FP01778; 42FC14745; 42FR09262; 42S01248; 42FP01855; 42FS86720; 42FT48521; 42T29128; 42GC09331; 42T29166; 42FE89487; 42FY54962; 42FJ25411; 42R75970; 42FJ25415; 42FJ25426; 42FP02096; 42FR09541; 42S01299; 42FP02164; 42FS87036; 42FE89738; 42X93965; 42R76080; 42K73873; 42FY55530; 42FW24320; 42FT49145; 42FH30943; 42G51800; 42H42656; 42L18182; 42X95754; 42L18885; 42FW25808; 42J54932; 42T31952; 42GS00091; 42FY58222; 42X97267; 42FX37195; 42T33419; 42FT51218; 42FR13746; 42J56320; 42X99784; 42J56672; 42GS02007; 42FX38429; 42K77697; 42FJ29389; 42GS02147; 42FT52111; 42GS02320; 42T34299; 42R79190; 42GC12641; 42FH35085; 42GS02509; 42J57025; 42T34535; 42FR14728; 42FX39460; 42FH35912; 42FR16537; 42K79507; 42FP07542; 42GS05379; 42FP08044; 42FG15013; 42FH38035; 42H45608; 42S09475; 42FR19529; 42T38927; 42J60615; 42R82601; 42FH38847; 42FX44325; 42FR20428; 42G57322; 42GE20896; 42FC20185; 42J62490; 42G57855; 42FY65616; 42GT06076; 42X11341; 42S13088; 42FR23408; 42X12294; 42G58827; 42J65036; 42J65656; 42GC19207; 42GC19403; 42J66118; 42FY68678; 42R87050; 42S16700; 42GE23950; 42S15779; 42FQ30098; 42S15858; 42W46282; 42J67374; 42FR27493; 42GE24867; 42J67510; 42FX51450; 42GT09019; 42FW28723; 42FW28741; 42FG21636; 42FX51795; 42GS14057; 42FP17550; 42FK72737; 42S17380; 42K86097; 42L33714; 42GS14524; 42FY70348; 42W46697; 42W46920; 42FR28885; 42FF00777; 42FY70871; 42FS94875; 42K88149; 42FT66986; 42GC22493; 42FK73459; 42GS16278; 42FH46147; 42FS95385; 42FJ41705; 42GT11407; 42T47055; 42FG24377; 42FP21685; 42GE28365; 42GS18470; 42K90300; 42R91583; 42G63752; 42FH48245; 42FY73968; 42GC24357; 42FP22670; 42FK74477; 42FW34872; 42FW34918; 42FH48985; 42FW34999 Class II Blood products, which were not screened for antibodies according to the reagent manufacturer's instructions, were distributed. 199 components B-1296-13
Platelets Pheresis Leukocytes Reduced 42KP12009; 42KW21131; 42KW23881; 42KW32826; 042KW33193 Class II Blood products, which were not screened for antibodies according to the reagent manufacturer's instructions, were distributed. 4 components B-1297-13
Red Blood Cells 42FZ04668; 42FQ07085; 42G40637; 42Q78142; 42K57455; 42X70520; 42GC01832; 42FY42018; 42S96094; 42G43536; 42FE80206; 42GC03025; 42FP94339; 42FC12027; 42H38306; 42G45141; 42R70525; 42K63770; 42GF00087; 42GC04186; 42X79525; 42FX25436; 42F57319; 42FE85263; 42H42171; 42GC07199; 42K69861; 42GQ00947; 42GE12459;42R75067; 42FR08846; 42K72538; 42FF87015; 42GW00822; 42H41922; 42H42001; 42FT47934; 42G50965; 42FX32315; 42FY54715; 42FH29950; 42FH29952; 42FE89385; 42FG08750; 42FZ04668; 42FX32821; 42W37413; 42FE89690; 42FK67898; 42FF87745; 42FQ18227; 42FE89800; 42R76089; 42FX33179; 42FF87875; 42FR10445; 42FC15239; 42FZ05440; 42L18360; 42H42959; 42GW01149; 42FW25652; 42GW01166; 42G52689; 42R77333; 42W39053; 42FP04088; 42FE92188; 42GQ02161; 42F59943; 42FP04467; 42FF89640; 42FQ20201; 42FX37359; 42FY58678; 42FG12022; 42J56537; 42S04645; 42FX38323; 42FG12246; 42X00136; 42F60609; 42W40533; 42FP05906; 42FC16758; 42GE17473; 42W40923; 42R80473; 42FR17226; 42L24243; 42FG14862; 42H45314; 42S08856; 42FC18434; 42R81577; 42GS06844; 42FK70290; 42GK01123; 42L25375; 42FP09719; 42L26574; 42J61392; 42GW02619; 42GT05538; 42GS08851; 42FX45740; 42T41101; 42FX47488; 42FK71589; 42FG19047; 42GW03072; 42GS11320; 42FC21422; 42GW03167; 42FK72004; 42T43436; 42FQ29372; 42M21467; 42L31825; 42R87247; 42FR26882; 42GQ01660; 42GW03782; 42GW03913; 42FF02862; 42GK01702 Class II Blood products, which were not screened for antibodies according to the reagent manufacturer's instructions, were distributed. 126 components B-1298-13
Red Blood Cells (Apheresis) Leukocytes Reduced 42C18441; 42E48391; 42E48501; 42GX00897; 42N21930; 42Y48405; 42FN17577 Class II Blood products, which were not screened for antibodies according to the reagent manufacturer's instructions, were distributed. 7 components B-1299-13
Red Blood Cells Leukocytes Removed Washed 42FG09596 Class II Blood products, which were not screened for antibodies according to the reagent manufacturer's instructions, were distributed. 1 component B-1300-13
Red Blood Cells Deglycerolized 42GQ00737 Class II Blood products, which were not screened for antibodies according to the reagent manufacturer's instructions, were distributed. 1 component B-1301-13
-
-